Dr. Bradley Thompson reports
ONCOLYTICS BIOTECH INC. ANNOUNCES VOTING RESULTS FROM ITS ANNUAL MEETING OF SHAREHOLDERS
Oncolytics Biotech Inc. has released voting results from its annual meeting of shareholders held on Thursday, May 5, 2016. A total of 40.0 per cent of the issued and outstanding common shares of the corporation was represented either in person or by proxy at the meeting.
On a vote by ballot, the seven nominees proposed by management were elected as directors of Oncolytics to serve until the corporation's next annual meeting of shareholders or until their successors are elected or appointed, with shares represented at the meeting voting in favour of individual nominees as shown in the table.
Director For % Withheld %
Matthew Coffey 11,694,506 81.09 2,727,635 18.91
Angela Holtham 11,697,631 81.11 2,724,510 18.89
J. Mark Lievonen 11,912,962 82.60 2,509,179 17.40
Wayne Pisano 11,936,135 82.76 2,486,006 17.24
William G. Rice 11,846,524 82.14 2,575,617 17.86
Bernd R. Seizinger 11,894,102 82.47 2,528,039 17.53
Bradley Thompson 12,172,372 84.40 2,249,769 15.60
In addition to the election of all nominees listed in the management information circular dated March 15, 2016, as directors, Oncolytics shareholders approved all other resolutions placed before the meeting (all voting conducted by ballot). These included: fixing the number of directors of the corporation for the ensuing year at seven and appointing Ernst & Young LLP as auditor of the corporation.
Please refer to the company's management information circular available on SEDAR for more details on the matters covered at the annual meeting. Final voting results on all matters voted on at the annual meeting will also be filed on SEDAR.
We seek Safe Harbor.
© 2024 Canjex Publishing Ltd. All rights reserved.